Skip to main content

Abstract

Reporting of suspected adverse reactions to drugs in the UK; Spontaneous reporting scheme (reporting primarily by patients in contrast to active drug safety monitoring, prescription-event monitoring by health professionals) established 1964 and operated by the MHRA in UK; the system is completely voluntary whereby physicians but also dentists, coronors and patients are encouraged to report (other countries accept only reporting of side effects by health care professionals); incomplete information provided often limit it’s use; → see also casecontrol study, epidemiology, EudraVigilance, MedWatch, pharmacovigilance, who collaborating centre for international drug monitoring.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag/Wien

About this chapter

Cite this chapter

(2009). yellow card programme. In: Dictionary of Pharmaceutical Medicine. Springer, Vienna. https://doi.org/10.1007/978-3-211-89836-9_1484

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-89836-9_1484

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-89835-2

  • Online ISBN: 978-3-211-89836-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics